Comments
Commented by Nico Popp on July 16th, 2026 | 07:05 CEST
Turning Data into Returns: The Strategies Behind Palantir and S&P Global—How Aspermont Combines Data and Commodities
Digitalization is creating a veritable flood of data. But raw data in its unstructured form has no economic value. It is like a raw material that must first be refined and contextualized through in-depth industry expertise. Anyone who wants to stay competitive today must base their decisions on high-quality, processed data. Industry estimates consistently show that data analysts and data scientists spend, on average, more than 50% of their daily work time searching for and formatting data sets. It is no wonder that, according to market researchers, the global data monetization market is projected to grow to as much as USD 25 billion by 2034. In this article, we explore who is leading the way in this fast-paced environment and what innovative approaches are available.
Read
Commented by Fabian Lorenz on July 16th, 2026 | 07:00 CEST
100% Upside Potential, a Downgrade, and a Sell-Off: Renk, OHB, and Almonty
Analysts see around 100% upside potential in shares of Almonty Industries. Following discussions with the company's CEO, they have raised both their earnings estimates and their price target to USD 33. Even under what they describe as conservative assumptions, the stock is expected to trade at a 2027 P/E ratio of below 10. Analysts are less optimistic about Renk Group. While the transmission manufacturer is expected to deliver solid growth, its valuation is no longer considered attractive. In addition, the long-term shift in defense procurement from tanks toward drones could become a headwind for the company. As a result, the stock has been downgraded. The situation at OHB is even more dramatic. The aerospace company's shares have fallen by more than 50% in roughly two months. Following the recently completed capital increase, investors are now expected to refocus on the company's underlying operational performance.
Read
Commented by Tarik Dede on July 15th, 2026 | 11:10 CEST
The Perfect Storm: Wars Are Driving Energy Stocks Like Occidental Petroleum, American Atomics, and First Solar
The war in the Persian Gulf is escalating again. There appears to be no chance of a peaceful resolution between the warring parties at this time. Meanwhile, refineries in Russia are burning, which is also jeopardizing diesel supply in Germany. Prices for oil, gas, and other energy commodities are rising again. The markets have reacted swiftly, driving up shares in the energy sector. One thing is clear: a precarious situation is unfolding, especially as oil reserves are dwindling even in the US, despite record-high production there. However, the high prices also encourage us to look beyond the oil market. The comeback of nuclear energy and the continued rise of solar power offer opportunities. That is why we are taking a look today at the stocks of Occidental Petroleum, American Atomics, and First Solar.
Read
Commented by Armin Schulz on July 15th, 2026 | 11:05 CEST
Act Now: Siemens Energy, RE Royalties, and Nordex—Before the Power Shortage Sends Share Prices Soaring
Electricity is evolving from a mere factor of production into a strategic currency. While Germany's energy-intensive industry has seen a 15.2% decline in production since 2022, and the AI boom is already partially overloading the grids, a systemic shortage is becoming apparent. However, this creates significant business potential for companies that integrate infrastructure, scale up physical generation, and finance projects with strong capital. Three players demonstrate how this structural shortage is being transformed into sustainable cash flows: Siemens Energy, the backbone of grid stability; RE Royalties, a partner in green financing; and Nordex, the driving force behind wind power.
Read
Commented by André Will-Laudien on July 15th, 2026 | 11:00 CEST
Sharp Swings in the Life Sciences Sector: Bayer, Vidac Pharma, BioNTech, Moderna, and Evotec in the Spotlight
Things are really heating up here! Cancer research is currently undergoing a historic turning point thanks to the convergence of cell analysis and digital precision. With a new management team, BioNTech is attempting to transition its revolutionary mRNA platform from COVID-19 to personalized cancer vaccines, while Bayer is strategically focusing on next-generation targeted radionuclide therapies. In the agricultural sector, the first signs of relief are finally emerging, as glyphosate is now being negotiated at the supranational level and has been classified as non-harmful by US authorities. At the same time, drug discovery company Evotec is grappling with a new revenue warning—and this one is particularly severe. Vidac Pharma is also coming into focus as a highly specialized innovator by blocking cancer metabolism to decisively manipulate the tumour microenvironment. These four distinct approaches impressively demonstrate that the victory over cancer no longer lies solely in traditional chemotherapies, but rather in highly specialized biotech companies and data-driven alliances. With so much news on the table, volatility is sure to follow.
Read
Commented by Armin Schulz on July 15th, 2026 | 10:55 CEST
Portfolio Booster 2026: Staying Ahead of NATO's Military Build-Up with Rheinmetall, Volatus Aerospace, and TKMS
The era of tank divisions is largely over. Today, air and sea domains are merging into a networked battlefield where autonomous drones, AI-powered sensors, and maritime surveillance systems are the decisive forces. The NATO summit in Ankara and Germany's record budget of EUR 108 billion are massively accelerating this technological transformation. For investors, this means focusing on the next generation of air and maritime defence. Three companies embody the full scope of this transformation: the full-service provider Rheinmetall, the agile drone pioneer Volatus Aerospace, and the maritime systems partner TKMS.
Read
Commented by Matthias Schomber on July 15th, 2026 | 08:45 CEST
AI, Oncology, and Defense: TeamViewer, BioNTech, and Antimony Resources—A Great Mix for Your Portfolio!
Created and published on behalf of Antimony Resources Corp.
The stock market is a place of extremes, and today we are looking at a trio—TeamViewer, BioNTech, and Antimony Resources—that comes from three different sectors. There is a German software pioneer that, after painful setbacks, is suddenly showing clear signs of life again. There is a once-celebrated vaccine hero pumping billions into a risky but revolutionary future in cancer therapy—while still holding a substantial cash reserve. And then there is a Canadian mineral explorer digging deep into the earth for a material without which our modern world would simply grind to a halt—one that is also crucial for the defense industry. It is precisely this mix of a software-AI turnaround, a biotech-oncology transformation, and mineral potential that makes the market so incredibly exciting. Join us on a journey through three fascinating corporate stories.
Read
Commented by Lars Winter on July 15th, 2026 | 08:40 CEST
Almonty, Sandvik, and Airbus: Three Stocks for the Battle Over Critical Raw Materials
Tungsten has long been a niche topic on the stock market. But this extremely hard metal is used, among other things, in cutting tools, semiconductors, aviation, and defense—and China dominates the supply chain. As a result, the critical raw material has become systemically important and is taking center stage in Western industrial and security policy. With Almonty Industries, Sandvik, and Airbus, we present three stocks that allow investors to profit across the value chain.
Read
Commented by Jens Castner on July 15th, 2026 | 08:35 CEST
Between the Oil Price Rally and Climate Billions: How Shell, Eni, and Zefiro Methane Are Profiting
The escalating conflict between the US and Iran is driving oil prices sharply higher—and with them, the share prices of energy companies like Shell and Eni. For their shareholders, that is the good news. The bad news: ironically, the very oil multinationals currently profiting from the crisis are viewed by the public as greedy climate offenders. To polish up their image, they are among the largest buyers of voluntary CO₂ credits. Many of these, however, are of dubious quality. Anyone looking for a solution to this problem almost inevitably ends up at Zefiro Methane, a largely undiscovered small-cap stock from Canada. The company addresses precisely the issues where Shell and Eni are struggling the most.
Read
Commented by Nico Popp on July 15th, 2026 | 08:30 CEST
Built on Sand? Barrick Mining Under Pressure, Rio Tinto Facing Headwinds, and North Arrow Minerals in a Strong Position
The demand for strategic metals, the challenging geopolitical environment, and new exploration methods—these factors are prompting established corporations and smaller exploration companies to adapt their business models in the face of these multifaceted challenges. While the major producers are streamlining their portfolios, which have grown over the years and are sometimes complex, smaller companies are demonstrating agility by divesting marginal projects and focusing on promising deposits in politically stable regions. We examine these developments and highlight exciting companies.
Read